ABSTRACT
Bioadhesion, the adherence of two phases, at least one of which is biological in nature, is a topic of increasing interest to the pharmaceutical scientist. Bioadhesion can be regarded as a useful phenomenon, facilitating the design of novel polymeric drug delivery systems. However, it can also be a clinically unhelpful or potentially dangerous problem, responsible, in part, for the formation of microbial biofilm on medical devices, a primary cause of clinical infection in, for example, intensive care situations.
